Safeguard Scientifics (NYSE:SFE) Earning Somewhat Positive News Coverage, Accern Reports

Headlines about Safeguard Scientifics (NYSE:SFE) have trended somewhat positive recently, according to Accern Sentiment. The research group identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Safeguard Scientifics earned a news sentiment score of 0.15 on Accern’s scale. Accern also gave news stories about the asset manager an impact score of 45.6135080714513 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Safeguard Scientifics (NYSE:SFE) traded up $0.25 on Friday, reaching $12.45. 214,419 shares of the company’s stock traded hands, compared to its average volume of 134,683. The stock has a market capitalization of $254.13, a P/E ratio of -2.77 and a beta of 1.29. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.45. Safeguard Scientifics has a 12 month low of $10.65 and a 12 month high of $14.40.

Safeguard Scientifics (NYSE:SFE) last announced its earnings results on Thursday, October 26th. The asset manager reported ($0.91) earnings per share for the quarter, beating the consensus estimate of ($1.11) by $0.20. During the same quarter in the previous year, the company earned ($1.18) earnings per share. equities research analysts anticipate that Safeguard Scientifics will post -4.47 EPS for the current year.

SFE has been the subject of a number of research reports. Zacks Investment Research raised shares of Safeguard Scientifics from a “hold” rating to a “buy” rating and set a $16.00 price objective for the company in a research report on Thursday, November 2nd. Keefe, Bruyette & Woods reaffirmed a “mkt perform” rating and set a $13.25 price target on shares of Safeguard Scientifics in a research report on Wednesday, December 6th. Finally, ValuEngine lowered shares of Safeguard Scientifics from a “hold” rating to a “sell” rating in a research report on Tuesday, November 14th.

TRADEMARK VIOLATION NOTICE: “Safeguard Scientifics (NYSE:SFE) Earning Somewhat Positive News Coverage, Accern Reports” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://www.dispatchtribunal.com/2018/01/20/safeguard-scientifics-sfe-earning-somewhat-favorable-press-coverage-analysis-finds.html.

Safeguard Scientifics Company Profile

Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.

Insider Buying and Selling by Quarter for Safeguard Scientifics (NYSE:SFE)

Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply